title: Evaluation of and recommendation for the nomenclature of the CPB2 gene product (also known as TAFI and proCPU): communication from the SSC of the ISTH.
authors.affiliation: Research Department of Haematology, University College London and Katherine Dormandy Haemophilia Centre and Thrombosis Unit, London, UK.
authors.forename: J H
authors.initials: JH
authors.lastname: Foley
authors.affiliation: Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, ON, Canada.
authors.forename: P Y
authors.initials: PY
authors.lastname: Kim
authors.affiliation: Laboratory for Medical Biochemistry, University of Antwerp, Antwerp, Belgium.
authors.forename: D
authors.initials: D
authors.lastname: Hendriks
authors.affiliation: Division of Hematology, School of Medicine, Stanford University, Stanford, CA, USA.
authors.forename: J
authors.initials: J
authors.lastname: Morser
authors.affiliation: Laboratory for Therapeutic and Diagnostic Antibodies, KU Leuven, Leuven, Belgium.
authors.forename: A
authors.initials: A
authors.lastname: Gils
authors.affiliation: Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK.
authors.forename: N J
authors.initials: NJ
authors.lastname: Mutch
mesh_terms: D025901:Carboxypeptidase B2 / Q000145:classification* / Q000235:genetics / Q000378:metabolism; D032921:Consensus; D005342:Fibrinolysis; D006801:Humans; D046650:Medical Subject Headings; D009626:Terminology as Topic
chemical_list: C585364:CPB2 protein, human; D025901:Carboxypeptidase B2